S243: antibody and t-cell response six months after initiation of bnt162b2 vaccination in patients with multiple myeloma or chronic lymphatic b-cell leukemia compared to healthy controls

L. D. Heftdal, L. Pérez-Alós, S. R. Ham, J. R. Madsen,K. Fogh, C. C. Kronborg, A. P. Vallentin,R. B. Hasselbalch,S. R. Ostrowski, R. Frikke-Schmidt,E. Sørensen,L. Hilsted, H. Bundgaard,K. Iversen,P. Garred,S. D. Nielsen, K. Grønbæk

HemaSphere(2022)

引用 0|浏览0
暂无评分
关键词
bnt162b2 vaccination,multiple myeloma,antibody,t-cell,b-cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要